According to a newly released study subjects who consumed cannabis typically decrease their driving speed and demonstrated few other significant changes. The study, titled Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects, was published in the journal Drug and Alcohol Dependence.
According to the results of a small pilot study vaping CBD products might lead to a positive urine test for marijuana.
The study tested people after use of cannabidiol (CBD) samples, some containing tiny amounts of THC (the psychoactive ingredient in marijuana), reports Reuters. One-third of those who vaped CBD-dominant cannabis had positive urine tests for THC, according to the report in the Journal of Analytical Toxicology.
The use of cannabis or cannabis-related products is associated with subjective benefits in women with endometriosis. This is according to a new study, titled Self-reported efficacy of cannabis for endometriosis pain, which was published in the Journal of Minimally Invasive Oncology.
According to a new study – titled A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers – around six in ten primary care physicians believe that medical cannabis is a “legitimate” therapeutic option. The study was published in the journal BMC Family Practice.
According to a new study published by the US Centers for Disease Control and Prevention, the use of marijuana among youth has declined since Washington State legalized marijuana for recreational purposes.
According to a new study titled Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in multiple rodent models of nicotine dependence, the administration of the cannabis compound THCV (tetrahydrocannabivarin) reduces nicotine cravings and use in rodents.
The study was published by the British Journal of Pharmacology, as well as the U.S. National Institute of Health
According to a study published in the journal Social Science & Medicine, and epublished by the National Institute of Health, those who consume marijuana for therapeutic purposes often to do so reduce pain and anxiety symptoms.
According to a new study, those with a history of marijuana use are less likely to develop the non-alcoholic fatty liver disease (NAFLD) than those who haven’t used cannabis.
The study, titled “Cannabis consumption and non-alcoholic fatty liver disease: A three years longitudinal study in first-episode non-affective psychosis patients”, was published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry.